Croda International Past Earnings Performance
Past criteria checks 1/6
Croda International's earnings have been declining at an average annual rate of -22.1%, while the Chemicals industry saw earnings growing at 2.7% annually. Revenues have been declining at an average rate of 1.1% per year. Croda International's return on equity is 2.9%, and it has net margins of 3.6%.
Key information
-22.15%
Earnings growth rate
-22.64%
EPS growth rate
| Chemicals Industry Growth | 4.35% |
| Revenue growth rate | -1.06% |
| Return on equity | 2.94% |
| Net Margin | 3.65% |
| Next Earnings Update | 28 Jul 2026 |
Recent past performance updates
Recent updates
CRDA: Cluster Of Recent Upgrades Will Support Re Rating Potential
The updated analysis trims Croda International's fair value estimate slightly to £47.67 from £47.96, as analysts factor in recent target changes and upgrades that reflect adjusted assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts adjusting ratings and targets in quick succession.
CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Fair Value Outlook
Analysts have raised their fair value estimate for Croda International from £23.00 to £28.65, citing recent upgrades, higher price targets, and updated assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International shows a mix of supportive and cautious views, with several firms revisiting their ratings and price targets in quick succession.CRDA: Recent Upgrades And Higher 3,280 Price Level Will Support Re Rating
Analysts have nudged their fair value estimate for Croda International slightly lower to about £47.96 from £48.16, reflecting modest adjustments to discount rate, revenue growth, profit margin and future P/E assumptions, alongside mixed but generally constructive recent research, including both target cuts and upgrades. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts updating their views through rating changes and revised price targets.CRDA: Higher Price Move To 3,280 And Modest P/E Reset Signal Upside
Narrative Update The analyst price target for Croda International has been raised to £3,280, an increase of £250. Analysts reference recent target moves from major banks, along with small adjustments to revenue growth, profit margin, discount rate and future P/E assumptions.CRDA: Higher Price References And Modest P/E Reset Will Support Upside Potential
Narrative Update The analyst price target for Croda International has been raised. Our fair value estimate has moved slightly higher to reflect recent increases in Street targets to around £32 per share, supported by analysts pointing to updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations.
CRDA: Higher Fair Value Assumptions Will Drive Reappraisal Of Margin Resilience
Analysts have raised their price target on Croda International by £4.00. This reflects updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following recent research updates.CRDA: Refined Assumptions And Lower P/E Will Support Higher Share Price
Analysts have trimmed their price target for Croda International by a small amount, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Valuation Changes Fair Value: trimmed slightly from £48.67 to £48.04 per share.CRDA: Activist Pressure Will Drive Reappraisal Of Margin Resilience And Future Re Rating
Analysts have trimmed their price target for Croda International to £34.02 from £34.46, reflecting slightly more cautious assumptions on revenue growth and profit margin, along with a modestly higher discount rate and a higher future P/E multiple. Valuation Changes Fair Value Estimate: trimmed slightly to £34.02 from £34.46.Is There An Opportunity With Croda International Plc's (LON:CRDA) 26% Undervaluation?
Jan 21
CRDA: Refreshed Q4 Guidance And Earnings Outlook Will Support Higher Share Price
Croda International's updated analyst price target has moved slightly higher, with recent revisions in the range of £30.50 to £33.00 per share, supported by analysts' refreshed assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research shows a cluster of modestly higher fair value views for Croda International, with price targets in a relatively tight range of £30.50 to £33.00 per share.Croda International Plc's (LON:CRDA) Popularity With Investors Is Clear
Jan 06CRDA: Activist Pressure Will Drive Future Reappraisal Of Margin Resilience
The analyst price target for Croda International has edged higher to approximately £31.00. This reflects modest improvements in forecast growth and valuation multiples as analysts point to stabilizing end markets and potential upside from strategic and activist driven initiatives, despite mixed target revisions across the Street.Should You Investigate Croda International Plc (LON:CRDA) At UK£26.70?
Dec 05CRDA: Activist Pressure Will Drive A Reappraisal Of Margin Resilience
Analysts have nudged up their price target on Croda International by about £1, placing it in the low £30s per share. They point to a stabilizing outlook, reflected in modestly higher Street targets and expectations that prior commoditization concerns may have been overstated.Is Croda International (LON:CRDA) Using Too Much Debt?
Nov 20CRDA: Activist Pressure And Commoditization Concerns Will Shape The Next Share Move
Croda International's analyst price target has seen a modest upward revision to 3,150 GBp from 3,000 GBp. This reflects analysts' view that recent sector updates and firm-specific catalysts support a slightly higher fair value for the shares. Analyst Commentary Recent research updates on Croda International have highlighted a mix of optimism and caution.CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year
Croda International's analyst price target has been modestly raised, with the new consensus target increasing to approximately £31.00 from £30.00. Analysts cite slight improvements in revenue growth expectations and a lower discount rate as reasons for the update.Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Croda International's analyst consensus price target has seen a modest uptick, rising by £0.50 to £31.00. Analysts cite improved profit margins as offsetting softer revenue growth expectations.Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around
Oct 06Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Analysts have revised Croda International's price target downward from £36.00 to £31.00, citing shifts in fair value and an improving revenue growth outlook. Ongoing activist pressures are seen as a potential positive for shares despite persistent margin concerns.Croda International Plc's (LON:CRDA) P/E Is On The Mark
Sep 18Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America
Croda International’s consensus price target saw a modest reduction to £35.23 as both future P/E and revenue growth expectations remained stable. What's in the News Croda International is prioritizing organic investment with a focus on higher returns, risk management, and faster cash payback, while reducing CapEx as a percentage of sales from 2026 onwards.Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly
Aug 15Croda International Plc's (LON:CRDA) Intrinsic Value Is Potentially 35% Above Its Share Price
Jul 12Here's Why Croda International (LON:CRDA) Can Manage Its Debt Responsibly
May 08
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Croda International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 25 | 1,699 | 62 | 629 | 0 |
| 30 Sep 25 | 1,684 | 101 | 569 | 0 |
| 30 Jun 25 | 1,668 | 140 | 508 | 0 |
| 31 Mar 25 | 1,648 | 149 | 505 | 0 |
| 31 Dec 24 | 1,628 | 159 | 502 | 0 |
| 30 Sep 24 | 1,629 | 161 | 502 | 0 |
| 30 Jun 24 | 1,630 | 163 | 503 | 0 |
| 31 Mar 24 | 1,662 | 167 | 490 | 0 |
| 31 Dec 23 | 1,695 | 171 | 477 | 0 |
| 30 Sep 23 | 1,769 | 182 | 492 | 0 |
| 30 Jun 23 | 1,843 | 194 | 507 | 0 |
| 31 Mar 23 | 1,966 | 422 | 523 | 0 |
| 31 Dec 22 | 2,089 | 649 | 539 | 0 |
| 30 Sep 22 | 2,086 | 680 | 523 | 0 |
| 30 Jun 22 | 2,083 | 711 | 508 | 0 |
| 31 Mar 22 | 1,986 | 516 | 504 | 0 |
| 31 Dec 21 | 1,890 | 321 | 501 | 0 |
| 30 Sep 21 | 1,771 | 284 | 453 | 0 |
| 30 Jun 21 | 1,651 | 247 | 406 | 0 |
| 31 Mar 21 | 1,521 | 224 | 369 | 0 |
| 31 Dec 20 | 1,390 | 202 | 332 | 0 |
| 30 Sep 20 | 1,363 | 204 | 321 | 0 |
| 30 Jun 20 | 1,336 | 207 | 311 | 0 |
| 31 Mar 20 | 1,357 | 216 | 311 | 0 |
| 31 Dec 19 | 1,378 | 224 | 311 | 0 |
| 30 Sep 19 | 1,388 | 230 | 279 | 0 |
| 30 Jun 19 | 1,399 | 235 | 247 | 0 |
| 31 Mar 19 | 1,393 | 237 | 219 | 0 |
| 31 Dec 18 | 1,387 | 239 | 191 | 0 |
| 30 Sep 18 | 1,378 | 241 | 192 | 0 |
| 30 Jun 18 | 1,369 | 244 | 193 | 0 |
| 31 Mar 18 | 1,371 | 241 | 194 | 0 |
| 31 Dec 17 | 1,373 | 237 | 194 | 0 |
| 30 Sep 17 | 1,358 | 226 | 190 | 0 |
| 30 Jun 17 | 1,342 | 214 | 187 | 0 |
| 31 Mar 17 | 1,293 | 206 | 174 | 0 |
| 31 Dec 16 | 1,244 | 197 | 162 | 0 |
| 30 Sep 16 | 1,185 | 192 | 148 | 0 |
| 30 Jun 16 | 1,126 | 187 | 134 | 0 |
| 31 Mar 16 | 1,104 | 184 | 127 | 0 |
| 31 Dec 15 | 1,082 | 181 | 119 | 0 |
| 30 Sep 15 | 1,078 | 178 | 118 | 0 |
| 30 Jun 15 | 1,074 | 175 | 118 | 0 |
Quality Earnings: CRDA has high quality earnings.
Growing Profit Margin: CRDA's current net profit margins (3.6%) are lower than last year (9.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRDA's earnings have declined by 22.1% per year over the past 5 years.
Accelerating Growth: CRDA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CRDA had negative earnings growth (-60.9%) over the past year, making it difficult to compare to the Chemicals industry average (-16.6%).
Return on Equity
High ROE: CRDA's Return on Equity (2.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/03 21:20 |
| End of Day Share Price | 2026/05/01 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Croda International Plc is covered by 33 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Knight | Barclays |
| Katie Richards | Barclays |
| Amy Lian | Barclays |